Cho Youngki, Do Junghwa, Jung Sunyoung, Kwon Ohyun, Jeon Jae Yong
Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, 05505, Seoul, South Korea.
Department of Physical Therapy, Graduate School, Yonsei University, Wonju, South Korea.
Support Care Cancer. 2016 May;24(5):2047-2057. doi: 10.1007/s00520-015-3005-1. Epub 2015 Nov 5.
The aim of this study was to evaluate the effects of physical therapy (PT) combined with manual lymphatic drainage (MLD) on shoulder function, pain, lymphedema, visible cords, and quality of life (QOL) in breast cancer patients with axillary web syndrome (AWS).
In this prospective, randomized trial, 41 breast cancer patients with visible and palpable cords on the arm and axilla and a numeric rating scale (NRS) pain score of >3 were randomly assigned to PT (3 times/week for 4 weeks; n = 20) and PT combined with MLD (5 times/week for 4 weeks; PTMLD; n = 21) groups. MLD was performed by a physical therapist and the patients themselves during week 1 and weeks 2-4, respectively. Arm volume, shoulder function (muscular strength; active range of motion; and disabilities of the arm, shoulder, and hand [DASH]); QOL (European Organization for Research and Treatment of Cancer Core and Breast Cancer-Specific QOL questionnaires), and pain (NRS) were assessed at baseline and after 4 weeks of treatment.
QOL including functional and symptom aspects, shoulder flexor strength, DASH, and NRS scores were significantly improved in both groups after the 4-week intervention (P < 0.05). NRS score and arm volume were significantly lower in the PTMLD group than in the PT group (P < 0.05). Lymphedema was observed in the PT (n = 6), but not PTMLD, group (P < 0.05).
PT improves shoulder function, pain, and QOL in breast cancer patients with AWS and combined with MLD decreases arm lymphedema.
本研究旨在评估物理治疗(PT)联合手法淋巴引流(MLD)对患有腋窝网状综合征(AWS)的乳腺癌患者的肩部功能、疼痛、淋巴水肿、可见条索以及生活质量(QOL)的影响。
在这项前瞻性随机试验中,41例手臂和腋窝有可见且可触及条索、数字评分量表(NRS)疼痛评分>3的乳腺癌患者被随机分为PT组(每周3次,共4周;n = 20)和PT联合MLD组(每周5次,共4周;PTMLD组;n = 21)。MLD分别由物理治疗师在第1周以及患者本人在第2 - 4周进行。在基线和治疗4周后评估手臂体积、肩部功能(肌肉力量、主动活动范围以及手臂、肩部和手部功能障碍[DASH])、生活质量(欧洲癌症研究与治疗组织核心问卷和乳腺癌特异性生活质量问卷)以及疼痛(NRS)。
4周干预后,两组患者包括功能和症状方面的生活质量、肩部屈肌力量、DASH评分和NRS评分均显著改善(P < 0.05)。PTMLD组的NRS评分和手臂体积显著低于PT组(P < 0.05)。PT组(n = 6)观察到淋巴水肿,而PTMLD组未观察到(P < 0.05)。
PT可改善患有AWS的乳腺癌患者的肩部功能、疼痛和生活质量,联合MLD可减轻手臂淋巴水肿。